What is the mortality rate associated with left main coronary artery lesions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 2, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Mortality Associated with Left Main Coronary Artery Lesions

Untreated significant left main coronary artery (LMCA) disease carries a mortality rate of approximately 50% within a few years after diagnosis, with high early mortality of approximately 2% per month among hospital survivors over the first 6 months. 1, 2

Mortality Based on Treatment Approach

Untreated/Medically Managed LMCA Disease

  • Mortality is extremely high in patients with significant LMCA stenosis who receive only medical therapy
  • In patients deemed unsuitable for CABG, mortality reaches 54.6% during follow-up 2
  • Patients who decline surgical intervention still face mortality rates of approximately 17.4% 2

Surgical Management (CABG)

  • CABG has traditionally been considered the gold standard for LMCA disease 1
  • Mortality rates with CABG for LMCA disease:
    • In-hospital/operative mortality: 4.7% (range 1.8-7.7%) 1
    • 30-day mortality in recent trials: 2.1% 1
    • Long-term follow-up mortality: 11.4% at approximately 15 months 2

Percutaneous Coronary Intervention (PCI)

  • PCI mortality rates vary significantly based on clinical presentation and anatomical factors:
    • Elective PCI for stable LMCA disease: 0-4.3% in-hospital mortality 1
    • Long-term mortality (15 months): 15.8% 2
    • Contemporary registry data shows 6.0% 30-day mortality and 18.5% mortality at 33.5 months 3
    • Emergency PCI for acute coronary syndrome involving LMCA: 35% at 30 days, rising to 58% at 5 years 4

Factors Affecting Mortality in LMCA Disease

Clinical Factors Associated with Higher Mortality

  • Cardiogenic shock (71.4% in-hospital mortality vs 10% without shock) 1, 4
  • Myocardial infarction presentation 1
  • Left ventricular ejection fraction ≤30% 5
  • Severe mitral regurgitation (grade 3 or 4) 5
  • Advanced age 3
  • Diabetes mellitus 3
  • Elevated creatinine (≥2.0 mg/dL) 5
  • Out-of-hospital cardiac arrest 4

Anatomical Factors

  • Lesion location significantly impacts outcomes:
    • Ostial or mid-shaft LMCA lesions have better outcomes than distal/bifurcation lesions 1
    • Bifurcation lesions have higher restenosis rates (up to 42%) 1
    • Multivessel disease in addition to LMCA disease increases mortality 3
    • Severe lesion calcification 5

Procedural Factors (for PCI)

  • Transradial access is associated with lower long-term mortality 3
  • Higher operator and center LMCA PCI experience correlates with better survival 3
  • Successful restoration of coronary flow improves prognosis 4
  • Use of drug-eluting stents versus bare-metal stents improves outcomes 3

Low-Risk Subgroups

In patients <65 years old with left ventricular ejection fraction >30% and without shock, the 1-year mortality after LMCA PCI was only 3.4% 5. This suggests that carefully selected patients may have relatively good outcomes with PCI.

Comparing Treatment Strategies

  • The SYNTAX trial showed comparable outcomes between PCI and CABG for left main disease at 1-2 years, but with higher repeat revascularization rates in the PCI group 1
  • For patients with isolated LMCA disease or LMCA plus single-vessel disease, PCI may provide similar outcomes to CABG 1
  • For complex LMCA disease (SYNTAX score ≥33) or LMCA plus multivessel disease, CABG appears to offer better outcomes 1

Recommendations Based on Current Guidelines

Current guidelines recommend:

  1. CABG as the primary treatment for significant LMCA stenosis (Class I recommendation) 1
  2. PCI as a reasonable alternative to CABG in selected patients with:
    • Low anatomical complexity (SYNTAX score <22)
    • Ostial or trunk LMCA lesions
    • High surgical risk (STS-predicted operative mortality >5%) 1

Pitfalls and Caveats

  • Distal bifurcation LMCA lesions have worse outcomes with PCI compared to ostial/mid-shaft lesions 1
  • Patients with LMCA disease presenting with MI and cardiogenic shock have extremely high mortality regardless of treatment 1, 4
  • Careful surveillance with coronary angiography is recommended after PCI for LMCA disease due to the risk of restenosis 1
  • The risk of stent thrombosis in LMCA can be catastrophic, emphasizing the importance of optimal stent deployment and adherence to dual antiplatelet therapy 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Does a 68-year-old woman without comorbidities (co-existing medical conditions) with a proximal occlusion of the Left Main Coronary Artery (LMCA) and an otherwise negative work-up require a Transesophageal Echocardiogram (TEE)?
Does alcohol affect simple ovarian cysts?
Is placing an aortic stent (aortic stent) considered an open heart procedure?
Can omeprazole be diluted in 0.9% sodium chloride?
Can omeprazole (Prilosec) be mixed with ondansetron (Zofran)?
What is a joint effusion?
What inhaler has minimum cardiac risk for a patient with asthma and significant cardiovascular history?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question